Radiation-induced pulmonary fibrosis (RIPF), one type of pulmonary interstitial diseases, is frequently observed following radiation therapy for chest cancer or accidental radiation exposure. Current treatments against RIPF frequently fail to target lung effectively and the inhalation therapy is hard to penetrate airway mucus. Therefore, this study synthesized mannosylated polydopamine nanoparticles (MPDA NPs) through one-pot method to treat RIPF. Mannose was devised to target M2 macrophages in the lung through CD 206 receptor. MPDA NPs showed higher efficiency of penetrating mucus, cellular uptake and ROS-scavenging than original polydopamine nanoparticles (PDA NPs) in vitro. In RIPF mice, aerosol administration of MPDA NPs significantly alleviated the inflammatory, collagen deposition and fibrosis. The western blot analysis demonstrated that MPDA NPs inhibited TGF-β1/Smad3 signaling pathway against pulmonary fibrosis. Taken together this study provide a novel M2 macrophages-targeting nanodrugs through aerosol delivery for the prevention and targeted treatment for RIPF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.colsurfb.2023.113353 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A stimuli-responsive drug delivery system based on konjac glucomannan, carboxymethyl chitosan and mesoporous polydopamine nanoparticles.
Int J Biol Macromol
December 2024
Jiangsu Key Laboratory of Advanced Catalytic Materials and Technology, School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China. Electronic address:
A stimuli-responsive drug delivery system is developed for controlled delivery of curcumin (Cur) and chemo-photothermal therapy of breast cancer (BC). Cur is first loaded into mesoporous polydopamine nanoparticles (mPDA NPs) by π-π stacking, and then the Cur loaded mPDA NPs (mPDA NPs@Cur) are encapsulated in the hydrogels prepared through the crosslinking of oxidized konjac glucomannan (oxKGM) and carboxymethyl chitosan (CMCS). Owing to the pH-sensitivity of the hydrogels and the outstanding photothermal conversion capability of mPDA NPs, the release of Cur from the hydrogels can be greatly accelerated in acidic media upon near infrared (NIR) irradiation.
View Article and Find Full Text PDFMesoporous Polydopamine Nanotherapeutics for MRI-Guided Cancer Photothermal and Anti-Inflammatory Therapy.
Int J Nanomedicine
October 2024
School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
Article Synopsis
- Photothermal therapy (PTT) shows promise in combating cancer but faces challenges, including inflammation and recurrence risks; combining PTT with anti-inflammatory treatments may improve its effectiveness.
- The study developed mesoporous dopamine nanoparticles (MAGM NPs) using Gd, arginine, and the anti-inflammatory drug meloxicam, aiming to enhance anti-cancer and anti-inflammatory effects while enabling MRI imaging.
- Test results on a mouse model of breast cancer revealed that MAGM NPs improved targeted anticancer effects under MRI guidance, while also boosting photothermal efficiency and reducing inflammation.
Drug-Loaded Mesoporous Polydopamine Nanoparticles in Chitosan Hydrogels Enable Myocardial Infarction Repair through ROS Scavenging and Inhibition of Apoptosis.
ACS Appl Mater Interfaces
November 2024
Chinese PLA Medical School & Department of Cardiology, The Second Medical Center National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing 100853, China.
In this study, we synthesized mesoporous polydopamine nanoparticles (MPDA NPs) using an emulsion-induced interface assembly strategy and loaded epigallocatechin gallate (EGCG) into MPDA NPs via electrostatic attraction to form EGCG@MPDA NPs. In the post myocardial infarction (MI) environment, these interventions specifically aimed to eliminate reactive oxygen species (ROS) and facilitate the repair of MI. We further combined them with a thermosensitive chitosan (CS) hydrogel to construct an injectable composite hydrogel (EGCG@MPDA/CS hydrogel).
View Article and Find Full Text PDFAnti-oxidative mesoporous polydopamine-based hypotensive nano-eyedrop for improved glaucoma management.
Colloids Surf B Biointerfaces
January 2025
State Key Laboratory of Ophthalmology, Optometry and Vision Science, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; National Engineering Research Center of Ophthalmology and Optometry, Institute of Biomedical Engineering, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address:
Conventional hypotensive eye drops remain suboptimal for glaucoma management, primarily due to their limited intraocular bioavailability and the growing concern regarding ocular surface side effects. Therefore, there is an urgent need to develop innovative intraocular pressure (IOP)-lowering formulations that not only possess enhanced corneal penetration ability but also provide ocular surface protection. Herein, anti-oxidative mesoporous polydopamine nanoparticles (MPDA NPs) were explored as a nano-carrier for Brimonidine to address the above issues.
View Article and Find Full Text PDFPhotothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles.
Mater Today Bio
October 2024
Research Center of Nano Technology and Application Engineering, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, China.
Article Synopsis
- * Researchers have developed mannose-modified mesoporous polydopamine nanosystems (Man-mPDA NPs) to target macrophages for delivering the anti-TB drug rifampicin, and to use photothermal therapy (PTT) for killing Mtb-infected macrophages.
- * The Rif@Man-mPDA NPs not only enhance drug delivery and effective thermal treatment, but also boost the immune response in host cells, reducing Mtb loads and tissue damage in a mouse model, presenting a promising new approach for CTB treatment
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!